Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 181-185

  Gonsalves, Susan ^a   Watson, John ^b   Ashton, Cynthia ^a  

^a Box 384   (United States)

^b PFIZER INC   (United States)

Author keywords

CP 122,721; emesis; ferret; tachykinin NK1 receptor antagonist

Indexed keywords

3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; CISPLATIN; COPPER SULFATE; CP 132687; IPECAC; LOPERAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENANTIOMER; FERRET; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PRIORITY JOURNAL; STEREOSPECIFICITY; SUBCUTANEOUS DRUG ADMINISTRATION; SYRUP;

EID: 0029893106     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00216-6     Document Type: Article

References (15)

1. 3 Receptor Antagonists, eds. F.D. King, B. Jones and G.J. Sanger (CRC Press, Boca Raton, FL) p. 255.
2. Andrews, P.L.R., C.J. Davis, S. Bingham, H.I.M. Davidson, J. Hawthorn and L. Maskell, 1990, The abdominal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity, Can. J. Physiol. Pharmacol. 68, 325.
3. 3 receptor antagonist BRL 43694, Br. J. Cancer 58, 644.
4. 3 receptors, Neuropharmacology 31, 735.
5. 1 receptor antagonist, CP-99,994, in ferrets, Eur. J. Pharmacol. 249, R3.
6. Carpenter, D.O., D.B. Briggs and N.L. Strominger, 1983, Response of neurons of canine area postrema to neurotransmitters and peptides, Cell. Mol. Neurobiol. 3, 113.
7. Carpenter, D.O., D.B. Briggs and N. Strominger, 1984, Behavioral and electrophysiological studies of peptide-induced emesis in dogs, Fed. Proc. 43, 2952.
8. Gardner, C.J., C. Bountra, K.T. Bunce, T.J. Dale, C.C. Jordan, D.J. Twissel and P. Ward, 1994, Anti-emetic activity of neurokinin NK-1 receptor antagonist is mediated centrally in the ferret, Br. J. Pharmacol. 112, 516P.
9. Leslie, R.A., 1985, Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus, Neurochem. Int. 7, 191.
10. Leslie, R.A. and J.A. Reynolds, 1992, Functional anatomy of the emetic circuitry in the brainstem, in: Mechanisms and Control of Emesis, Vol. 223, eds. A.L. Bianchi, L. Grelot, A.D. Miller and G.L. King (Colloque INSERM/John Libbey Eurotext) p. 19.
11. McLean, S., A. Ganong, P.A. Seymour, R.M. Snider, M.C. Desai, T. Rosen, D.K. Bryce, K.P. Longo, L.S. Reynolds, G. Robinson, A.W. Schmidt, C. Siok and J. Heym, 1993, Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor, J. Pharmacol. Exp. Ther. 267, 472.
12. 1 receptor, J. Pharmacol. Exp. Ther. (in press).
13. 1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret, Eur. J. Pharmacol. 250, R5.
14. 1) receptor antagonist CP-99,994, Neuropharmacology 34, 1697.
15. 1 receptor, Br. J. Pharmacol. 115, 84.